Hypera Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Hypera wird ein jährliches Gewinn- und Umsatzwachstum von 12.9% bzw. 9.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 13.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.5% betragen.

Wichtige Informationen

12.9%

Wachstumsrate der Gewinne

13.2%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	19.9%
Wachstumsrate der Einnahmen	9.4%
Zukünftige Eigenkapitalrendite	17.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	06 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 16

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 31

Recent updates

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Jun 20

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 16

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 31

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Jul 19

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Jun 28

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Apr 14

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Mar 25

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Mar 04

Gewinn- und Umsatzwachstumsprognosen

BOVESPA:HYPE3 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	10,397	2,410	2,270	N/A	6
12/31/2025	9,385	2,088	2,296	N/A	10
12/31/2024	8,613	1,807	1,957	N/A	10
3/31/2024	8,043	1,701	1,803	2,574	N/A
12/31/2023	7,915	1,649	1,581	2,396	N/A
9/30/2023	8,189	1,773	1,247	2,118	N/A
6/30/2023	8,086	1,742	1,157	2,072	N/A
3/31/2023	7,751	1,694	1,160	2,029	N/A
12/31/2022	7,546	1,705	529	2,039	N/A
9/30/2022	7,051	1,640	205	1,825	N/A
6/30/2022	6,648	1,636	91	1,688	N/A
3/31/2022	6,260	1,660	-29	1,560	N/A
12/31/2021	5,937	1,618	494	1,399	N/A
9/30/2021	5,446	1,577	583	1,293	N/A
6/30/2021	4,902	1,462	-798	1,218	N/A
3/31/2021	4,445	1,382	-805	1,163	N/A
12/31/2020	4,089	1,322	-749	1,183	N/A
9/30/2020	3,883	1,243	-759	1,125	N/A
6/30/2020	3,803	1,165	497	959	N/A
3/31/2020	3,726	1,106	387	803	N/A
12/31/2019	3,295	1,189	462	824	N/A
9/30/2019	3,294	1,252	563	853	N/A
6/30/2019	3,233	1,225	610	855	N/A
3/31/2019	3,180	1,164	775	1,005	N/A
12/31/2018	3,724	1,135	846	1,066	N/A
9/30/2018	3,789	1,288	896	1,108	N/A
6/30/2018	3,716	1,251	771	981	N/A
3/31/2018	3,613	1,200	735	943	N/A
12/31/2017	3,500	1,111	N/A	933	N/A
9/30/2017	3,291	819	N/A	903	N/A
6/30/2017	3,226	795	N/A	950	N/A
3/31/2017	3,216	743	N/A	868	N/A
12/31/2016	3,228	647	N/A	882	N/A
9/30/2016	3,202	557	N/A	828	N/A
6/30/2016	3,129	432	N/A	683	N/A
3/31/2016	3,046	349	N/A	518	N/A
12/31/2015	2,957	345	N/A	324	N/A
9/30/2015	1,589	263	N/A	330	N/A
6/30/2015	2,039	326	N/A	430	N/A
3/31/2015	2,447	360	N/A	556	N/A
12/31/2014	2,768	338	N/A	664	N/A
9/30/2014	4,498	400	N/A	705	N/A
6/30/2014	4,423	357	N/A	698	N/A
3/31/2014	4,359	249	N/A	652	N/A
12/31/2013	4,259	259	N/A	666	N/A
9/30/2013	4,167	332	N/A	597	N/A
6/30/2013	4,047	324	N/A	661	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HYPE3Das prognostizierte Gewinnwachstum (12.9% pro Jahr) liegt über der Sparquote (9.9%).

Ertrag vs. Markt: HYPE3Die Erträge des Unternehmens (12.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (14% pro Jahr).

Hohe Wachstumserträge: HYPE3Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: HYPE3Die Einnahmen des Unternehmens (9.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (7.2% pro Jahr).

Hohe Wachstumseinnahmen: HYPE3Die Einnahmen des Unternehmens (9.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: HYPE3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.5%).

Hypera Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Now 22% undervalued after recent price drop

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Now 23% undervalued after recent price drop

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued after recent price drop

Hypera S.A., Annual General Meeting, Apr 23, 2024

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Is Hypera (BVMF:HYPE3) A Risky Investment?

Hypera S.A. to Report Q3, 2024 Results on Nov 06, 2024

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

New major risk - Financial position

Second quarter 2023 earnings released: EPS: R$0.79 (vs R$0.72 in 2Q 2022)

Is Hypera (BVMF:HYPE3) A Risky Investment?

First quarter 2023 earnings released

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

Full year 2022 earnings released: EPS: R$2.69 (vs R$2.56 in FY 2021)

Hypera S.A. to Report Q4, 2022 Results on Feb 16, 2023

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Third quarter 2022 earnings released

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Hypera Reportedly in Merger Talks with Grupo NC

Hypera S.A. to Report Q3, 2022 Results on Oct 28, 2022

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

First quarter 2022 earnings: Revenues in line with analyst expectations

Less than half of directors are independent

Hypera S.A. to Report Q1, 2022 Results on Apr 28, 2022

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Hypera S.A., Annual General Meeting, Apr 26, 2022

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Full year 2021 earnings: EPS exceeds analyst expectations

Hypera S.A. to Report Fiscal Year 2021 Results on Feb 24, 2022

Hypera S.A.(BOVESPA:HYPE3) dropped from Brazil Valor BM&FBOVESPA Index

Third quarter 2021 earnings released: EPS R$0.73 (vs R$0.56 in 3Q 2020)

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS R$0.48 (vs R$0.39 in 1Q 2020)

New 90-day low: R$30.52

Full year 2020 earnings released

Revenue and earnings beat expectations

Hypera S.A. to Report Q4, 2020 Results on Feb 26, 2021

New 90-day high: R$35.31

New 90-day high: R$32.34

Market bids up stock over the past week

New 90-day low: R$28.80

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings beat expectations

New 90-day low: R$30.22

Hypera S.A. (BOVESPA:HYPE3) completed the acquisition of Boehringer Ingelheim Buscopan brand and other assets from Boehringer Ingelheim International Gmbh, Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. and Boehringer Ingelheim Pharma GmbH & Co. KG.

New 90-day low - R$31.65

Bunge Alimentos S.A. acquired Food division of Hypera S.A. (BOVESPA:HYPE3) for BRL 180 million.

New 90-day high - R$36.25

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken